Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 4/20 | 0.67 |
| ▸ | HTR2A | P28223 | 3/20 | 0.67 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.59 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | HTR1B | P28222 | 3/20 | 0.54 |
| ▸ | HTR1A | P08908 | 2/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.54 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | HTR1E | P28566 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | HTR7 | P34969 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | HRH1 | P35367 | 1/20 | 0.54 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.54 |
| ▸ | DRD3 | P35462 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19335885 | 0.87 | HTR1D (0.61) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL18383116 | 0.86 | HTR1D (0.69) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL8344495 | 0.85 | HTR1D (0.73) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL12233833 | 0.85 | HTR2A (0.67) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL1722931 | 0.83 | HTR1D (0.65) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL31567644 | 0.83 | HTR1D (0.65) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL24814500 | 0.81 | MTNR1A (0.63) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL6116786 | 0.81 | TSHR (0.69) | HTR1DHTR2AMTNR1AMTNR1BLMNA | |
| SCHEMBL12013054 | 0.81 | HTR1D (0.73) | HTR1DHTR1BHTR1APOLB | |
| SCHEMBL12634153 | 0.80 | HTR1D (0.61) | HTR1DHTR2AMTNR1AMTNR1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023065716-A1 | POLYPEPTIDE AND APPLICATION THEREOF AS CCK RECEPTOR AGONIST/ANTAGONIST | 中国科学院香港创新研究院再生医学与健康创新中心有限公司 | 2023-04-27 | — | — | WO | disclosed |
| US-20220204497-A1 | NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME | DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2022-06-30 | — | — | US | disclosed |
| EP-3928804-A2 | HYDROGEL INCLUDING SEROTONIN-MODIFIED HYALURONIC ACID AND USE THEREOF | Cellartgen Inc. (KR) | 2021-12-29 | — | — | EP | disclosed |
| EP-3892616-A1 | AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE | Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) | 2021-10-13 | — | — | EP | disclosed |
| WO-2020114475-A1 | AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE | 上海济煜医药科技有限公司 | 2020-06-11 | — | — | WO | disclosed |
| EP-3330252-B1 | ISOPRENYL COMPOUNDS AND METHODS THEREOF | SIGNUM BIOSCIENCES INC (US) | 2020-02-12 | — | — | EP | disclosed |
| WO-2019113443-A2 | TRYPTOPHAN DERIVATIVES AS SWEETENERS | CHROMOCELL CORPORATION (US) | 2019-06-13 | — | — | WO | disclosed |
| EP-3330252-A2 | ISOPRENYL COMPOUNDS AND METHODS THEREOF | Signum Biosciences, Inc. (US) | 2018-06-06 | — | — | EP | disclosed |
| US-9758474-B2 | Immunomodulator and anti-inflammatory compounds | INCOZEN THERAPEUTICS PVT. LTD. (IN) | 2017-09-12 | — | — | US | disclosed |
| US-9758474-B2 | Immunomodulator and anti-inflammatory compounds | INCOZEN THERAPEUTICS PVT. LTD. (IN) | 2017-09-12 | — | — | US | disclosed |
| WO-2011138665-A1 | NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS | INCOZEN THERAPEUTICS PVT. LTD. (IN) | 2011-11-10 | — | — | WO | disclosed |
| US-20110275603-A1 | NOVEL IMMUNOMODULATOR AND ANTI-INFLAMMATORY COMPOUNDS | RHIZEN PHARMACEUTICALS SA (FR) | 2011-11-10 | — | — | US | disclosed |
| US-20110086001-A1 | COMPLIANT BIOCOMPATIBLE POLYMER COMPOSITIONS FOR MEDICAL USES | RUTGERS UNIVERSITY (US) | 2011-04-14 | — | — | US | disclosed |
| US-20110086001-A1 | COMPLIANT BIOCOMPATIBLE POLYMER COMPOSITIONS FOR MEDICAL USES | RUTGERS UNIVERSITY (US) | 2011-04-14 | — | — | US | disclosed |
| US-20100228343-A1 | PHASE-SEPARATED BIOCOMPATIBLE POLYMER COMPOSITIONS FOR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100228343-A1 | PHASE-SEPARATED BIOCOMPATIBLE POLYMER COMPOSITIONS FOR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY (US) | 2010-09-09 | — | — | US | disclosed |
| WO-2010042917-A1 | PHASE-SEPARATED BIOCOMPATIBLE POLYMER COMPOSITIONS FOR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-04-15 | — | — | WO | disclosed |
| EP-1465880-B1 | 5-SULPHANYL-4H-1,2,4-TRIAZOLE DERIVATIVES AND THEIR USE TO TREAT DISORDERS ASSOCIATED WITH SOMATOSTATINE | IPSEN PHARMA (FR) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008047883-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-04-24 | — | — | WO | disclosed |
| EP-1318980-B1 | HYDROXAMATE DERIVATIVES USEFUL AS DEACETYLASE INHIBITORS | NOVARTIS AG (CH) | 2007-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275603-A1 | NOVEL IMMUNOMODULATOR AND ANTI-INFLAMMATORY COMPOUNDS | DHODH, DLD, DHFR | HTR1D 4601/4885HTR2A 4338/4885MTNR1A 2591/4885 |
| US-20110086001-A1 | COMPLIANT BIOCOMPATIBLE POLYMER COMPOSITIONS FOR MEDICAL USES | BMP2, ECPAS, PLOD3 | HTR1D 4593/4885HTR2A 4334/4885MTNR1A 3481/4885 |
| US-20220204497-A1 | NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME | TPX2, AIMP2, CDYL2 | HTR1D 4595/4885HTR2A 3688/4885MTNR1A 3735/4885 |
| US-20100228343-A1 | PHASE-SEPARATED BIOCOMPATIBLE POLYMER COMPOSITIONS FOR MEDICAL USES | BMP2, PUF60, MYADM | HTR1D 4554/4885HTR2A 4496/4885MTNR1A 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.